In hospital cardiac arrest: a role for automatic defibrillation.
BACKGROUND
Sudden cardiac death (SCD) survival decreases by 10% for each minute of delay in defibrillation, however, survival rates of 98% can be achieved when defibrillation is accomplished within 30s of collapse. Recently, a fully automated external cardioverter-defibrillator (AECD) was approved by the FDA for in-hospital use. The AECD can be programmed to automatically defibrillate when a life threatening ventricular arrhythmia occurs. The purpose of this study was to assess the potential impact of in-hospital AECDs on the critical time to defibrillation in monitored hospital units.


METHODS
Mock emergency (n = 18) were conducted using simulated ventricular fibrillation in various monitored units. Observers were stationed to record the time staff responded to the arrhythmia, and the time to shock. These times were compared to an AECD protocol that defibrillates automatically in an average of 38.3 s from onset of arrhythmia (n = 18).


RESULTS
Staff versus AECD response time to arrhythmia (s) was 76.3 +/- 113.7 (CI 19.8-132.8) versus 7.6 +/- 0.6 (CI 7.3-7.9). Staff versus AECD time to shock was 169.2 +/- 103.1 (CI 117.9-220.4) versus 38.3 +/- 0.7 (CI 37.9-38.6). P-values are <0.0001 for differences between the groups.


CONCLUSIONS
The use of AECDs on monitored units would significantly reduce the critical time to defibrillation in patients with SCA. We anticipate this would translate to improved survival rates, and better neurologic outcomes.
Cusnir
Henry
H
Division of Cardiology, Maimonides Medical Center, 953 49th Street, Brooklyn, NY 11219, USA.
Tongia
Rohit
R
Sheka
Karthik P
KP
Kavesteen
David
D
Segal
Robert R
RR
Nowakiwskyj
Vera N
VN
Cassera
Frederick
F
Scherer
Hannah
H
Costello
Dolores
D
Valerio
Louise
L
Yens
David P
DP
Shani
Jacob
J
Hollander
Gerald
G
D004554:Electric Countershock; D004867:Equipment Design; D006323:Heart Arrest / Q000628:therapy*; D006760:Hospitalization; D006801:Humans; D013997:Time Factors; D014693:Ventricular Fibrillation / Q000628:therapy*